Laid off from ICU Medical.

Since buying Smiths Medical in 2022, ICU Medical has been closing plants it took on, saying its Keene, New Hampshire plant duplicated others. The former Smiths site in Oakdale, Minnesota was idle by the end of 2025. Earlier, after buying Pfizer's Hospira Infusion Systems business, ICU closed Dominican Republic plants.

What we know about ICU Medical severance and layoffs

  • 83 Oakdale service and distribution layoffs in ICU's July 2024 WARN letter
  • About 220 full-time employees at the Keene plant when ICU announced its closing
  • About 81 employees covered by the August 2023 Oakdale plant closing notice
  • About 265 employees affected when ICU's board approved closing its Slovakia plant in 2015
  • $30.0 million in 2025 restructuring charges, mainly facility closure and severance costs
  • 3 filings by ICU Medical and Smiths Medical in our WARN tracker

The most recent ICU Medical layoff we've found

Through September 2026, ICU booked $23.5 million in restructuring charges, mostly facility closure and severance costs, including $5.8 million in non-cash write-downs tied to leaving certain facilities early, ICU's September 2026 quarterly report shows.

What ICU Medical layoffs have meant for employees

ICU put the Keene closing down to overlap with its other plants. Tom McCall, a corporate vice president, told My Keene Now that the plant had performed well but was duplicative to other manufacturing facilities. The 2023 Oakdale letter cited the company's analysis of its operations at the site and of its larger U.S. manufacturing footprint, Medical Design Sourcing reported, and the 2024 letter, as MedTech Dive described it, an analysis of its U.S. service operations. The same outlet reported that ICU had bought Smiths Medical from Smiths Group for $2.35 billion in January 2022 and that, by July 2024, it had been eliminating duplicative pump service centers and planned to cut its manufacturing sites from 20 in 2022 to 10 by 2026. For anyone at a former Smiths Medical site, those are the reasons ICU has given so far, and at Keene it said the site's performance played no part.

ICU has closed acquired plants before. Its 2019 10-K note ties 2017 and 2018 restructuring charges to integrating the business it bought from Pfizer, covering severance from involuntary terminations and the closing of Dominican Republic plants acquired in that deal, and says most of the 2019 charges were a one-time charge for relocating the company's U.S. pump service depot into the Salt Lake City facility it already had. At Keene, ICU said all of the plant's manufacturing would go to other locations, the closest in Connecticut, so ICU planned to keep making what Keene made, at other sites.

The cuts weren't limited to the production floor. The 2023 Oakdale closing included engineering, maintenance, human resources, manager and supervisor jobs, the same Medical Design Sourcing report said, and the 2024 letter listed inspectors, supervisors and engineers beside the technicians. Keene's closing was set to come in phases through 2025, and the 2024 Oakdale letter spread its terminations over the last months of that year, so people at those two sites weren't all scheduled to leave on the same day. When ICU told Keene's workers about the closing, McCall said no one was being let go that day.

Since 2025, facility closure costs have been the larger part of ICU's restructuring charges, after a 2024 in which employee costs made up most of them, ICU's 2025 10-K note shows. Employee-related charges fell from $18.3 million in 2024 to $11.1 million in 2025. Through September 2026, the accrual table in its 2026 third-quarter filing showed about $12.4 million for facilities and $5.3 million for employees, and the filing booked another $5.8 million of non-cash write-downs for leaving certain facilities early separately from that table.

ICU links the plant consolidation to profit margins. The 2025 projects, led by integrating two large former Smiths Medical plants into the network, positioned the company to keep improving gross margins, chief executive Vivek Jain wrote in his April 2026 letter in the 2025 annual report, adding that much of the Smiths integration work was behind it and that many integration activities that had consumed cash were wrapping up. The 2026 third-quarter filing still showed spending on facility consolidations tied to the Smiths integration, so the plant work continued into 2026.

Since ICU sold 60 percent of its IV Solutions business to Otsuka Pharmaceutical Factory in 2025's second quarter, moving it into a joint venture, our WARN tracker leaves that venture's notices out of ICU's count. If you're claiming benefits after the Oakdale or Keene cuts, you can start from Minnesota unemployment benefits or New Hampshire unemployment benefits, and from California unemployment benefits for the San Jose jobs in ICU's 2019 notice.

A sourced history of ICU Medical layoffs

  • 2025, plant consolidation and restructuring charges

    ICU's 2025 restructuring charges of $30.0 million included $19.0 million for facility closures and $11.1 million for employee costs, per its 2025 10-K note. The chief executive's letter in its 2025 annual report says two large legacy Smiths Medical plants were integrated that year.

  • July 2024, Oakdale service and distribution site closing

    A July 16 letter filed in Minnesota said ICU would permanently shut its Oakdale service and distribution facility and lay off all 83 employees, mostly technicians, from September 16 through December 31, MedTech Dive reported. No union represented them.

  • April 2024, Keene, New Hampshire plant closing announced

    ICU told the roughly 220 full-time employees of the former Smiths Medical plant that it would shut in phases during 2025, and that they'd get severance pay, benefits and at least 60 days' notice, My Keene Now reported.

  • August 2023, Oakdale manufacturing plant closing notice

    ICU's August 17 letter told Minnesota it would permanently close the Oakdale manufacturing plant and lay off about 81 employees from October 29, with full closure planned for December 31, 2024, Medical Design Sourcing reported. Nobody at the plant held bumping rights, and no union represented its workers.

  • 2022, severance after the Smiths Medical purchase

    Most of ICU's $9.7 million in 2022 restructuring charges was severance tied to its January 6, 2022 acquisition of Smiths Medical, the 2022 10-K note shows.

  • 2019, charge to move U.S. pump service depot

    ICU's $8.4 million in 2019 restructuring charges, mostly severance and facility closure costs, were mainly a one-time charge to move its U.S. pump service depot to its existing Salt Lake City facility, plus other plant restructuring, the 2019 10-K note shows.

  • 2017 and 2018, closing Dominican Republic plants acquired from Pfizer

    Integrating Hospira Infusion Systems, bought from Pfizer, ICU booked 2017 and 2018 restructuring charges for severance from involuntary terminations and for closing Dominican Republic facilities it acquired, according to ICU's 10-K for 2019. Charges for 2017 totaled $18.8 million.

  • November 2015, Vrable, Slovakia plant closing

    ICU's board approved closing the Vrable plant on November 16, 2015, affecting about 265 employees, to use its Ensenada, Mexico facility more efficiently, and estimated $3.4 million in charges, a November 2015 8-K shows.

What to do if you're laid off from ICU Medical

ICU Medical layoff and severance questions

What severance has ICU Medical given laid-off employees?

ICU told Keene's workers in April 2024 that it was providing them severance pay and benefits, My Keene Now reported. For the 2015 Slovakia closing, ICU estimated about $1.3 million for severance, retention and other employee help, according to the November 2015 8-K. The 2025 10-K note puts employee-related restructuring charges, totals for the whole company, at $18.3 million in 2024 and $11.1 million in 2025.

Did ICU Medical close its Oakdale, Minnesota facility?

ICU's 2025 annual report lists its Oakdale building, a leased warehouse and device service center, as idle on December 31, 2025, and describes the Oakdale facility as Smiths Medical's before ICU acquired Smiths. An August 2023 notice covered closing the Oakdale manufacturing plant, Medical Design Sourcing reported, and a July 2024 letter covered shutting the Oakdale service and distribution facility and laying off all 83 employees, according to MedTech Dive.

Is ICU Medical closing the Smiths Medical plant in Keene, New Hampshire?

ICU said in April 2024 that the Keene plant would close in phases through 2025, with its manufacturing going to other locations, the nearest in Connecticut, My Keene Now reported. ICU sold the Keene property in 2025, yet its 2025 annual report listed the building, by then leased, as a warehouse and manufacturing site on December 31, 2025.

How many WARN notices has ICU Medical filed?

Our WARN tracker has 3 filings from ICU Medical and Smiths Medical, which ICU owns today. They're a 2019 ICU notice for 57 jobs in San Jose, California, the 2023 Oakdale notice, which Minnesota's 2023 WARN report lists as received August 17, and a 2006 Smiths Medical row from Duluth, Georgia, filed long before ICU bought Smiths. The July 2024 Oakdale letter and the Keene closing aren't among them.

Sources for this page